VRX.TO : Summary for VALEANT PHARMACEUTICALS INTL IN - Yahoo Finance

U.S. Markets open in 7 hrs 25 mins

Valeant Pharmaceuticals International, Inc. (VRX.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
21.94+0.74 (+3.49%)
At close: 3:59PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close21.20
Open21.05
Bid21.92 x
Ask22.00 x
Day's Range20.93 - 22.30
52 Week Range17.19 - 103.74
Volume2,196,247
Avg. Volume1,284,865
Market Cap7.48B
BetaN/A
PE Ratio (TTM)-3.34
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters8 hours ago

    Perrigo sells Tysabri royalty stream, delays annual report

    Drugmaker Perrigo Co Plc said on Monday it agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to privately held Royalty Pharma for up to $2.85 billion. Perrigo said it would delay the filing of its annual report until March, and would review past accounting practices, specifically its historical revenue recognition of its Tysabri sales. The company also said its chief financial officer, Judy Brown, was stepping down, to be replaced by an interim finance head.

  • Drugmakers pledge restraint, but prices will still soar
    Associated Press9 hours ago

    Drugmakers pledge restraint, but prices will still soar

    TRENTON, N.J. (AP) — Several big drugmakers are trying to quell the furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.

  • The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results
    Motley Fool9 hours ago

    The Only Number That Matters When Valeant Pharmaceuticals Reports Its Q4 Results

    Forget about Valeant's EPS -- this figure is far more important.